Table 1 Baseline demographics, pain and allodynia.
From: Effect of a single dose of pregabalin on herpes zoster pain
| Â | Placebo first group, n = 3 | Pregabalin first group, n = 5 |
|---|---|---|
Demographics | Â | Â |
   Age; median (range) | 77 (73-84) | 65 (22-76) |
   % Female | 33% | 40% |
Distribution of Zoster | Â | Â |
   Trigeminal | 0 | 1 |
   Cervical | 1 | 1 |
   Thoracic | 2 | 3 |
Severity of rash | Â | Â |
   Mild | 0 | 0 |
   Moderate | 100% a | 80% |
   Severe |  | 20% |
Days between outbreak and study entry; median (range) | 31 (31-37) | 23 (10-45b) |
Days between visit 1 and visit 2; median (range) | 2 (2-5) | 2 (2-5) |
Pain at V1, 0-100; median (range) | 63 (20-90) | 48 (16-90) |
Pain at V2, 0-100; median (range) | 55 (17-79) | 30 (9-94) |
Allodynia severity V1, 0-100; median (range) | 51 (19-74) | 37 (10-84) |
Allodynia severity V2, 0-100; median (range) | 20 (15-48) | 34 (0-70) |